NanoViricides, Inc. (NNVC) Stock Forecast & Price Target
Price as of Nov 17, 2026 (intraday, delayed) · Analyst estimates retrieved Nov 16, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)
Revenue and earnings estimates published by analysts covering NanoViricides, Inc. (NNVC), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.
For NanoViricides, Inc., analysts forecast revenue rising from $26.39M in 2023 to $133.50M in 2029; the average estimate for 2029 earnings per share is $0.95; 1 analyst contribute to these figures. These are forecasts published by analysts, not results.
Revenue forecast (USD)
The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.
Earnings per share forecast
NanoViricides, Inc. (NNVC) forecast — frequently asked questions
What are analysts forecasting for NanoViricides, Inc.'s earnings?
The average analyst estimate for NanoViricides, Inc. (NNVC) earnings per share in 2029 is 0.95, with individual estimates between 0.95 and 0.95.
How much revenue is NanoViricides, Inc. expected to make?
Analysts forecast NanoViricides, Inc. (NNVC) revenue of $133.50M in 2029, based on 1 published estimates.
How many analysts cover NNVC?
1 analyst contribute estimates for NanoViricides, Inc. (NNVC). Thin coverage makes an average less reliable.
Analyst forecasts for other Biotechnology stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.